Prospective biomarkers comprising Aβ42, t‐tau, p‐tau, tau/Aβ42 in CSF, as well as t‐tau, Aβ42/Aβ40, and NFL in peripheral blood, are related to AD progression, as summarized by a systematic review and analysis [129]. The gene discussed is MAPT; the disease is Alzheimer disease.